← Back to Search

Hypnotics

Insomnia Treatment for Insomnia

N/A
Waitlist Available
Led By Charles Morin, PhD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-2 (after 6-week treatment phase 2)
Awards & highlights

Study Summary

This trial is testing different treatments for insomnia disorder to see which are most effective, feasible, and adaptable. It is also testing a stepped care approach to see if it is effective for persistent insomnia.

Eligible Conditions
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-2 (after 6-week treatment phase 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-2 (after 6-week treatment phase 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Remission of insomnia
Secondary outcome measures
Anxiety
Mental Depression
Disability
+8 more

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Treatment as usual + Online CBTExperimental Treatment2 Interventions
Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores
Group II: Online cognitive behavior therapyExperimental Treatment1 Intervention
Online CBT- Internet self-help program for insomnia with 6 cores
Group III: MedicationExperimental Treatment1 Intervention
Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks (arms 1, 3, 4)
Group IV: In-person cognitive behavior therapyExperimental Treatment1 Intervention
Face-to-face CBT- Face-to-face therapy with 3 to 4 individual sessions in a period of 6 to 8 weeks.
Group V: Treatment as usualActive Control1 Intervention
Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks
Group VI: No additional treatmentActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Online CBT
2018
N/A
~480

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,343 Previous Clinical Trials
26,452,793 Total Patients Enrolled
7 Trials studying Insomnia
941 Patients Enrolled for Insomnia
Laval UniversityLead Sponsor
417 Previous Clinical Trials
171,972 Total Patients Enrolled
2 Trials studying Insomnia
447 Patients Enrolled for Insomnia
Charles Morin, PhDPrincipal InvestigatorUniversité Laval Centre d'étude des troubles du sommeil
1 Previous Clinical Trials
211 Total Patients Enrolled

Media Library

Hypnotics (Hypnotics) Clinical Trial Eligibility Overview. Trial Name: NCT03633305 — N/A
Insomnia Research Study Groups: Treatment as usual, Online cognitive behavior therapy, Treatment as usual + Online CBT, Medication, In-person cognitive behavior therapy, No additional treatment
Insomnia Clinical Trial 2023: Hypnotics Highlights & Side Effects. Trial Name: NCT03633305 — N/A
Hypnotics (Hypnotics) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03633305 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available for prospective study participants?

"Affirmative. Clinicaltrials.gov supports that this clinical trial is actively looking for volunteers and was first published on September 1st 2018, with the most recent update being made on April 5th 2022. 300 participants are needed across a single location."

Answered by AI

How many participants are participating in this clinical trial?

"Affirmative. Per clinicaltrials.gov, this trial is currently recruiting new participants since its initial posting on September 1st 2018 and the recent update of April 5th 2022. The research team needs to recruit 300 individuals from a single medical facility."

Answered by AI
~46 spots leftby Apr 2025